The European approval comes less than six months
after the green light from the U.S. Food and Drug Administration,
Sanofi added in a statement.
"We have just started roll-out in the U.S. and can now launch in
Europe and other regions in the world," Merial Chief Executive
Carsten Hellmann said.
(Reporting by James Regan; editing by
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.